JPS61265096A - Production of l-malic acid - Google Patents

Production of l-malic acid

Info

Publication number
JPS61265096A
JPS61265096A JP10564985A JP10564985A JPS61265096A JP S61265096 A JPS61265096 A JP S61265096A JP 10564985 A JP10564985 A JP 10564985A JP 10564985 A JP10564985 A JP 10564985A JP S61265096 A JPS61265096 A JP S61265096A
Authority
JP
Japan
Prior art keywords
acid
malic acid
prepibacterium
culture
resistance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP10564985A
Other languages
Japanese (ja)
Other versions
JPH0523747B2 (en
Inventor
Masato Terasawa
真人 寺沢
Shoichi Nara
昭一 奈良
Hideaki Yugawa
英明 湯川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Petrochemical Co Ltd
Original Assignee
Mitsubishi Petrochemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Petrochemical Co Ltd filed Critical Mitsubishi Petrochemical Co Ltd
Priority to JP10564985A priority Critical patent/JPS61265096A/en
Priority to GB08612030A priority patent/GB2175304B/en
Priority to US06/864,212 priority patent/US4912043A/en
Publication of JPS61265096A publication Critical patent/JPS61265096A/en
Publication of JPH0523747B2 publication Critical patent/JPH0523747B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PURPOSE:To obtain in high yield L-malic acid, by reacting fumaric acid (salt) in a solvent of water by the use of a culture mixture obtained by cultivating a specific bacterium aerobically or a treated material of it. CONSTITUTION:Fumaric acid or its salt is reacted in a solvent of water in the presence of a culture mixture obtained by cultivating aerobically a bacterium belonging to the genus Brevibacterium, having resistance to alpha-aminobutyric acid, especially a bacterium belonging to the genus Brevibacterium having positively provided resistance to alpha-aminobutyric acid and/or raised resistance to alpha-aminobutyric acid or of a treated material of it, to form L-malic acid.

Description

【発明の詳細な説明】 技術分野 本発明は、L−IJンゴ酸の製造法に関するものである
DETAILED DESCRIPTION OF THE INVENTION Technical Field The present invention relates to a method for producing L-IJ malic acid.

本発明の方法によれば高い収率でL−リンゴ酸を製造す
ることができる。
According to the method of the present invention, L-malic acid can be produced in high yield.

L−リンゴ酸は現在医薬用等に用いられているものであ
り、又将来食品用としての利用も期待されるものである
L-malic acid is currently used for medical purposes, and is also expected to be used for food purposes in the future.

先行技術 ■、−リンゴ酸の製造法としては、フマラーゼ活性を有
する微生物をフマール酸を含有する培地に培養し、培養
物からTJ−’)ンゴ酸を採取する醗酵法(例えば特公
昭41−16547号等参照)、及びフマラーゼ活性を
有する微生物中の酵素フマラーゼを用いてフマール酸ま
たはその塩からL−リンゴ酸を製造する酵素法〔例えば
The JournFLtof GenerFLtan
d Apgied Microbio/igy、ヱ、1
08〜116(1960)、European Jou
rnatof ApptiedMj crobi ol
ogyX3.169〜183(1976)など参照〕が
知られている。
Prior art ■ - As a method for producing malic acid, there is a fermentation method (for example, Japanese Patent Publication No. 41-16547 ), and enzymatic methods for producing L-malic acid from fumaric acid or its salts using the enzyme fumarase in microorganisms having fumarase activity [e.g., The JournFLtof GenerFLtan
d Apgied Microbio/igy, ヱ, 1
08-116 (1960), European Jou
rnatofApptiedMj crobiol
ogyX3.169-183 (1976), etc.] are known.

しかしながら、醗酵法によるL−リンゴ酸の製造では、
大規模な醗酵設備を要し、ざらにL−’Jンゴ酸の生成
収率が極めて低いため、高師となるなどの問題がある。
However, in the production of L-malic acid by fermentation method,
It requires large-scale fermentation equipment, and the production yield of L-'J malic acid is extremely low, resulting in problems such as high production.

公知の酵素法によるし一リンゴ酸の製法は、微生物のフ
マラーゼを利用してフマール酸からし一リンゴ酸を得る
ものであり、従って強力なフマラーゼ活性を有する微生
物を得ることが工業的生産への重要要素となっているが
、このような目的に合致する微生物を自然界から分離す
ることは多くの困難を伴ない工業化への障害となってい
た。
The known enzymatic method for producing monomalic acid uses microbial fumarase to obtain monomalic acid from fumaric acid. Therefore, it is important to obtain microorganisms with strong fumarase activity for industrial production. Although this has become an important element, isolating microorganisms that meet these purposes from the natural world has been accompanied by many difficulties and has been an obstacle to industrialization.

発明の概要 本発明者らは、上記問題点を解消すべく鋭意検討を行い
本発明を完成した。
SUMMARY OF THE INVENTION The present inventors conducted intensive studies to solve the above problems and completed the present invention.

即ち、本発明は、プレピバクテリウム属に属し、α−ア
ミノ酪酸耐性を有する微生物を好気的に培養して得られ
る培養物若しくはその処理物の存在下フマール酸または
その塩を水溶媒中で反応させてL−リンゴ酸を生成させ
ることを特徴とするし一リンゴ酸の製造法を提供するも
のである。
That is, the present invention provides fumaric acid or a salt thereof in the presence of a culture obtained by aerobically cultivating a microorganism belonging to the genus Prepibacterium and having resistance to α-aminobutyric acid, or a processed product thereof, in an aqueous solvent. The present invention provides a method for producing monomalic acid, which is characterized in that L-malic acid is produced by reacting with L-malic acid.

3里犯差圧煎皿里 本発明の方法に用いられる微生物は、プレピバクテリウ
ム属に稿し、α−アミノ酪酸耐性を有する微生物である
。この微生物は、該耐性機構を人為的に付辱された微生
物に限定されるものではなく、自然界における偶発的変
異によって該耐性機構を取得した微生物であってもよい
。この様な微生物の例としては、例えば特公昭57−2
6755号公報に開示されているプレピバクテリウム 
フラバム MJ−233(微工研菌寄第3068号)等
がある。
The microorganism used in the method of the present invention belongs to the genus Prepibacterium and is resistant to α-aminobutyric acid. This microorganism is not limited to a microorganism that has been artificially affected with the resistance mechanism, but may be a microorganism that has acquired the resistance mechanism through accidental mutation in nature. Examples of such microorganisms include, for example,
Prepibacterium disclosed in Publication No. 6755
There are Flavum MJ-233 (Feikoken Bibori No. 3068), etc.

本発明の方法に用いられる α−アミノ酪酸耐性を有す
る微生物は、上述の天然から取得されたそのままの微生
物でも用いられるが、好ましくはプレピバクテリウム属
に属し α−アミノ酪酸耐性を積極的に付与された及び
/又は高められて有する微生物が用いられる。この様な
微生物としては例えば特公昭59−28398号公報に
開示されているプレピバクテリウム フラバム MJ−
233−AB−41(微工研菌寄第3812号)等があ
る。
The microorganism having α-aminobutyric acid resistance used in the method of the present invention may be the above-mentioned naturally obtained microorganism, but preferably belongs to the genus Prepibacterium and is actively resistant to α-aminobutyric acid. Microorganisms with endogenous and/or enriched microorganisms are used. An example of such a microorganism is Prepibacterium flavum MJ-, which is disclosed in Japanese Patent Publication No. 59-28398.
233-AB-41 (Feikoken Bibori No. 3812), etc.

本発明の方法に好ましく使用される上述の、プレピバク
テリウム属に属し α−アミノ酪酸耐性を積極的に付与
された及び/又は高められて有する微生物は、プレピバ
クテリウム属に属し α−アミノ酪酸耐性を有する微生
物を公知の方法、例えば次の操作により誘導することが
できる。即ち、紫外線照射、あるいは化学的薬剤(例え
ばN−メチル−N′−二トローN−二トロソグアニジン
等)処理により例えばプレピバクテリウム フラバムM
J−233に変異を誘起せしめた後、この菌懸濁液をα
−アミノ−n−酪酸1011Jf / me金含有る平
板培地(尿素0.2%、硫安0.7%、K2HO4o、
05%、K2HPO40,05%、MgSO4・7H2
00,05%、Nact2W/ L、 Cact、+・
2H20219/l、 FeSO4・7H202m!/
L、 Mn504m4〜6T(zoXZn SO2・7
H202”t/ tN  ビオチン200μy7t、チ
アミン塩酸塩100μy/l、  α−アミノ−n−酪
酸1.0%、寒天2.0%、エタノール3容量%〔滅菌
後添加〕)に、30℃にて数日間培養し、生じた大コロ
ニーを分離することにより耐性変異株を得ることができ
る。
The above-mentioned microorganism belonging to the genus Prepibacterium and having α-aminobutyric acid resistance actively imparted and/or increased, which is preferably used in the method of the present invention, belongs to the genus Prepibacterium and has α-aminobutyric acid resistance. A microorganism resistant to aminobutyric acid can be induced by a known method, for example, by the following procedure. That is, for example, Prepibacterium flavum M is treated by ultraviolet irradiation or chemical agent treatment (for example, N-methyl-N'-nitro-N-nitrosoguanidine, etc.).
After inducing mutations in J-233, this bacterial suspension was
-Amino-n-butyric acid 1011 Jf/me gold-containing plate medium (urea 0.2%, ammonium sulfate 0.7%, K2HO4o,
05%, K2HPO40.05%, MgSO4・7H2
00,05%, Nact2W/L, Cact, +・
2H20219/l, FeSO4・7H202m! /
L, Mn504m4~6T (zoXZn SO2・7
H202"t/tN biotin 200μy7t, thiamine hydrochloride 100μy/l, α-amino-n-butyric acid 1.0%, agar 2.0%, ethanol 3% by volume [added after sterilization]) at 30°C. A resistant mutant strain can be obtained by culturing for days and separating the resulting large colonies.

ここで、本願発明において使用する微生物のα−アミノ
酪酸耐性は、α−アミノ酪酸2%を(注−1)の培地に
加え、30℃、3日間振盪培塗した時の相対生育度で定
義され、α−アミノ酪酸耐性を積極的に付与された及び
/又は高められて有する微生物の前記相対生育度は15
以上、好ましくけ30以上である。
Here, the α-aminobutyric acid resistance of the microorganism used in the present invention is defined as the relative growth rate when 2% α-aminobutyric acid is added to the medium (Note-1) and the culture is incubated at 30°C with shaking for 3 days. and the relative growth rate of microorganisms that have been actively conferred and/or enhanced with α-aminobutyric acid resistance is 15
It is preferably 30 or more.

なお、前記相対生育度11次式で示される。Note that the relative growth rate is expressed by the 11th-order equation.

(上式中、α−ABV!、DL−α−アミノ酪酸の略号
である) (注−1)使用培地組成及び培養方法 尿素0.2%、硫安0.7%、KH2PO40,05%
、K2HPO40,05%、MgSαC7H2O0,0
5%、酵母エキス0.01%、カザミノ酸0.01%、
FeSO4・7HzO24/ t、 MnSO4・4〜
6HzO2”%F/ l、 NaC12q/l、 Ca
Cjzφ2Hz0 2m1j’/L、  ZnSO4・
7H202”f/ Lz  ビチy!r>200p?/
”% チアミン塩酸1100μy/lからなる培地(D
L−α−アミノ酪酸は、表1に示す着を加える)10d
を口径24■の大型試験管に分注、120℃、10分間
滅菌後、微生物例えばプレピバクテリウム フラバム 
MJ−233−AB −41株を各々接種し、エタノー
ルを無菌条件にて0.3 d (3各音%)添加し、3
0℃で3日間振盪培養を行なった。
(In the above formula, α-ABV! is an abbreviation for DL-α-aminobutyric acid) (Note-1) Composition of the medium used and culture method Urea 0.2%, ammonium sulfate 0.7%, KH2PO40.05%
, K2HPO40,05%, MgSαC7H2O0,0
5%, yeast extract 0.01%, casamino acid 0.01%,
FeSO4・7HzO24/t, MnSO4・4~
6HzO2”%F/l, NaC12q/l, Ca
Cjzφ2Hz0 2m1j'/L, ZnSO4・
7H202”f/ Lz Bichiy!r>200p?/
A medium (D
For L-α-aminobutyric acid, add the ingredients shown in Table 1) 10d
Dispense into large test tubes with a diameter of 24 mm, sterilize at 120°C for 10 minutes, and remove microorganisms such as Prepibacterium flavum.
Each MJ-233-AB-41 strain was inoculated, 0.3 d (3% each) of ethanol was added under aseptic conditions, and 3
Shaking culture was performed at 0°C for 3 days.

(注−2)生育度0.Da 10 %相対生育度生育度
0.Ds+oは、61O即の波長における吸光度を示し
、この吸光度測定は東京大学農学部農芸化学教室実験農
芸化学上巻212頁、朝倉書店(1975)に従い測定
した。また、DL−α−アミノ酪酸無添加時の生育度0
.D61Gを100とし、相対生育度で表わす。
(Note-2) Growth rate 0. Da 10% Relative Viability Viability 0. Ds+o indicates absorbance at the immediate wavelength of 61O, and this absorbance was measured according to Experimental Agricultural Chemistry, Department of Agricultural Chemistry, Faculty of Agriculture, University of Tokyo, Volume 1, p. 212, Asakura Shoten (1975). In addition, the growth rate when DL-α-aminobutyric acid was not added was 0.
.. D61G is set as 100 and expressed as relative growth rate.

上述の定義に従い測定したプレピバクテリウムフラバム
 MJ−2a3及びプレピバクテリウム フラバム M
J−233−AB−41のDL−α−アミノ酪酸に対す
る相対生育度は表1に示す通りであった。
Prepibacterium flavum MJ-2a3 and Prepibacterium flavum M measured according to the above definitions
The relative growth rate of J-233-AB-41 to DL-α-aminobutyric acid was as shown in Table 1.

(以下余白) 表  1 上述したプレピバクテリウム属に属しα−アミノ酪酸耐
性を有する微生物を好気的に培養する。
(The following are blank spaces) Table 1 The above-mentioned microorganisms belonging to the genus Prepibacterium and having resistance to α-aminobutyric acid are cultured aerobically.

この時培養に使用される炭素源、窒素源、無機塩等の培
地組成は特に限定されるものではなく、例えば炭素源と
してエタノール、メタノール、n −パラフィン、糖蜜
等が、窒素源としてはアンモニア、硫酸アンモニウム、
塩化アンモニウム、硝酸アンモニウム、尿素等が、無機
塩としてはリン酸−水素カリウム、リン酸二水素カリウ
ム、硫酸マグネシウム等が用いられる。これらの炭素源
、窒素源および無機塩はそれぞれ単独又は混合して用い
ることができる。
The composition of the medium, including carbon sources, nitrogen sources, inorganic salts, etc., used in the culture is not particularly limited. For example, carbon sources include ethanol, methanol, n-paraffin, molasses, etc., and nitrogen sources include ammonia, molasses, etc. ammonium sulfate,
Ammonium chloride, ammonium nitrate, urea, etc. are used, and as the inorganic salt, potassium hydrogen phosphate, potassium dihydrogen phosphate, magnesium sulfate, etc. are used. These carbon sources, nitrogen sources and inorganic salts can be used alone or in combination.

更に、これらの他に菌の生育に必要であれば、ヘフトン
、肉エキス、酵母エキス、コーンステイープリカ=、カ
ザミノ酸、各種ビタミン等の栄養素を培地に添加するこ
とができる。
Furthermore, in addition to these nutrients, nutrients such as hefton, meat extract, yeast extract, cornstarch, casamino acid, and various vitamins can be added to the medium if necessary for the growth of the bacteria.

培養は通気攪拌、振盪等の好気的条件下で行ない、培養
温度は20〜40 ℃、好ましくは25〜35℃で行な
う。培養途中のpHは5〜1o1好ましくは7〜8付近
にて行ない、培養液中のpHの調整には酸、アルカリを
添加して行なう。
The culture is carried out under aerobic conditions such as aeration, stirring, and shaking, and the culture temperature is 20 to 40°C, preferably 25 to 35°C. The pH during the cultivation is kept at around 5-101, preferably around 7-8, and the pH in the culture solution is adjusted by adding acid or alkali.

培養開始時の炭素源例えばエタノール濃度は1〜5容敬
%、好ましくは2〜3容量%が適する。
The concentration of the carbon source, such as ethanol, at the start of the culture is suitably 1 to 5% by volume, preferably 2 to 3% by volume.

培養期間は2〜8日間、好ましくは4〜5日間である。The culture period is 2 to 8 days, preferably 4 to 5 days.

かくして得られた培養物は、活性の高いフマラーゼを含
有しているので、フマール酸またはそのナトリウム塩、
カルシウム塩等のフマール酸tiヲ原料として、これを
酵素反応によりL−リンゴ酸を収率よく製造することが
できる。
The culture thus obtained contains highly active fumarase, so fumaric acid or its sodium salt,
Using fumaric acid such as calcium salt as a raw material, L-malic acid can be produced in good yield by enzymatic reaction.

ここで、酵素反応には上述の様にして得られた培養物若
しくけその処理物が用いられるが、これらには上述の培
養液そのものの他、それに含まれている菌体、菌体の破
壊物、磨砕物および自己消化液等、培養で得られる全て
のものを含むものであり、更に菌体、菌体の破壊物、磨
砕物等を固定化したものも含むものである。
Here, the culture obtained as described above or its treated product is used for the enzyme reaction, but these include the culture solution itself, the bacterial cells contained therein, and the bacterial cells contained therein. It includes everything obtained by culturing, such as destroyed matter, ground matter, and autolyzed fluid, and also includes immobilized bacterial cells, disrupted bacterial bodies, ground matter, and the like.

本発明における酵素反応は、上記培養物若しくはその処
理物の存在下フマール酸またはその塩を水溶媒中で反応
させることにより行われる。
The enzyme reaction in the present invention is carried out by reacting fumaric acid or its salt in an aqueous solvent in the presence of the culture or its treated product.

該酵素反応は水溶媒中、pH4〜10、反応温度約15
〜約60℃、好ましくは約20〜約50℃で、通常的0
.5〜約48時間行われる。
The enzyme reaction is carried out in an aqueous medium at a pH of 4 to 10 and a reaction temperature of approximately 15
to about 60°C, preferably about 20 to about 50°C, typically 0
.. It is carried out for 5 to about 48 hours.

この酵素反応は水溶媒中で行われるが、水の他にリン酸
緩衝液、トリス塩酸緩衝液等の溶媒を10〜500 m
Mの(硬度で用いることもできる。又、反応液のpHを
4〜10に関節する為水酸化ナトリウム、水酸化カリウ
ム、水酸化アンモニウム等のアルカリ類、塩酸、硫酸等
の無機酸を添加することもできる。
This enzymatic reaction is carried out in an aqueous solvent, but in addition to water, a solvent such as phosphate buffer or Tris-HCl buffer is added at 10 to 500 m
M (hardness) can also be used.Also, in order to adjust the pH of the reaction solution to 4 to 10, alkalis such as sodium hydroxide, potassium hydroxide, and ammonium hydroxide, and inorganic acids such as hydrochloric acid and sulfuric acid are added. You can also do that.

フマール酸またはその塩の反応時の使用数には特に制限
はないが、一般には0.5〜30%(WVvol)の範
囲で使用するのが適当である。また、該培養物若しくけ
その処理物の使用量′も特に制限されるものではないが
、一般に0.5〜10%(wt/ vol )の範囲で
使用することができる。
There is no particular restriction on the number of fumaric acid or its salt used in the reaction, but it is generally appropriate to use it in the range of 0.5 to 30% (WVvol). Further, the amount of the culture or the processed material to be used is not particularly limited, but it can generally be used in the range of 0.5 to 10% (wt/vol).

培養物若しくはその処理物を用いてフマール酸と水を反
応せしめて得られる反応液中に生成したし一リンゴ酸の
分離・精練は、イオン交換樹脂、活性炭等による吸着、
脱着処理等の公知の方法により行なうことができる。
Separation and scouring of monomalic acid produced in the reaction solution obtained by reacting fumaric acid and water using a culture or its processed product can be carried out by adsorption with ion exchange resin, activated carbon, etc.
This can be done by a known method such as desorption treatment.

実験例 実施例1及び2 尿素4.Of、硫安14.Of、K1−1zPO40,
5t 。
Experimental Examples Examples 1 and 2 Urea4. Of, ammonium sulfate 14. Of, K1-1zPO40,
5t.

KzHPOa O,5f、 WIgF304・7H20
0,5f。
KzHPOa O, 5f, WIgF304・7H20
0.5f.

FeSO4拳7Hz06q、 Mn5O4s4〜6Hz
0 6gIf。
FeSO4 fist 7Hz06q, Mn5O4s4~6Hz
0 6gIf.

酵母エキス1.Of、カザミノ酸1.1llIF、ビオ
チン200μ?、チアミン塩酸塩100μv1水道水1
1からなる培地10dを口径24簡の大型試験管に分注
し、120℃、1゛o分間加圧滅菌し、無菌的にエタノ
ール0.3dを添加して前培養用培地とした。この培地
にプレピバクテリウム フラパAMJ−233(実施例
2)とプレピバクテリウム フラバムMJ−233−A
B−41(実施例1)を各々l白金Jflt植菌し、3
0℃で2日間振盪培養を行なった。
Yeast extract 1. Of, Casamino Acid 1.1llIF, Biotin 200μ? , thiamine hydrochloride 100 μv 1 tap water 1
10 d of a medium consisting of 1 was dispensed into large test tubes with a diameter of 24, sterilized under pressure at 120° C. for 1°, and 0.3 d of ethanol was added aseptically to prepare a preculture medium. In this medium, Prepibacterium flavum AMJ-233 (Example 2) and Prepibacterium flavum MJ-233-A were added.
B-41 (Example 1) was inoculated with 1 platinum Jflt each, and 3
Shaking culture was performed at 0°C for 2 days.

次に、−1記の前培養用培地組成と同一なる培地100
m/づつを500t/容計の2個の正角コルベンに分注
し、120℃、10分間加圧滅菌し、無菌的にエタノー
ル3−をそれぞれ添加して本培養用培地とし、−Ld己
2種の微生物の前培養液1.0mlをそれぞれ植菌して
30℃で3日間振盪培養を行った。
Next, a medium 100 having the same preculture medium composition as described in -1
m/m each into two square colbens of 500 t/volume, sterilized under pressure at 120°C for 10 minutes, and aseptically added ethanol 3- to each to prepare the main culture medium. 1.0 ml of the preculture solution of each of the two types of microorganisms was inoculated and cultured with shaking at 30° C. for 3 days.

かくして得られたそれぞれの培養物から一定歇の菌体全
集菌する為に、比濁法(0,Da+o )により0.0
a1oの値を10.0に水にて調整し、該調製液それぞ
れ100m/から遠心分離(4000rpmX15分間
)により集菌した。
In order to collect a constant number of bacterial cells from each culture obtained in this way, 0.0
The a1o value was adjusted to 10.0 with water, and bacteria were collected from each of the prepared solutions by centrifugation (4000 rpm for 15 minutes) from 100 m/min.

一方、フマール酸10?を水70dに加え、5N−Na
OH溶液にてpH6,0に調整後水で全曖を100m/
としだ後100m/容三角フラスコに5゜−を分注した
。この様な原料溶液を2間作製し、これらにさらにF記
集閑体をそれぞれ添加し、45℃で2時間振とうを行っ
た。反応終了後、遠心分離(4000rpm、15分間
)にて菌体を除去した上清液中に生成したし一リンゴ酸
針を高速液体クロマトグラフにて測定した結果、親株で
あるプレピバクテリウム・フラバムMJ−233の集菌
体を使用の場合、40■/ tie (実施例2)、ま
た積極的にα−アミノ−n−酪酸耐性を付与した萌株で
ちるプレピバクテリウム・フラバムMJ−233−AB
−41の集菌体を使用の場合、82’If/d(実施例
1)であった。
On the other hand, fumaric acid 10? was added to 70 d of water, and 5N-Na
After adjusting the pH to 6.0 with OH solution, the total pH was adjusted to 100 m/s with water.
After cooling, 5° of the mixture was dispensed into a 100 m Erlenmeyer flask. Such raw material solutions were prepared for 2 hours, and each of the aggregates described in F was added thereto, followed by shaking at 45° C. for 2 hours. After the reaction was completed, microbial cells were removed by centrifugation (4000 rpm, 15 minutes), and monomalic acid needles produced in the supernatant were measured using a high-performance liquid chromatograph. As a result, the parent strain Prepibacterium spp. When using a bacterial collection of Prepibacterium flavum MJ-233, 40 μ/tie (Example 2) was used. 233-AB
-41, the result was 82'If/d (Example 1).

また、各反応終了液50履1に6N−HCtm液を添加
しpi■を約2に調整後、強塩基性樹脂(ローム・アン
ド・ハース社製「アンバーライトIRA−400J、R
2C0a型)を充填したカラムに1市しL−リンゴ酸を
樹脂に吸着させた。次にIN−炭酸アンモニウムにて溶
出後濃縮し、L−リンゴ酸の粗結晶を析出させた。これ
をアセトンで洗浄し、乾燥した。プレピバクテリウム・
フラバムMJ−233の集菌体を使用の反応液50m/
からけL−リンゴ酸の結晶を1.2f、一方、プレピバ
クテリウム・フラバムMJ−233−AH−41の集菌
体を使用の反応液50wLlからはL L IJンゴ酸
の結晶を2,6f得た。
In addition, 6N-HCtm solution was added to 50 liters of each reaction completed solution to adjust pi to about 2, and then a strong basic resin (Amberlite IRA-400J, R manufactured by Rohm and Haas) was added.
L-malic acid was adsorbed onto the resin. Next, the mixture was eluted with IN-ammonium carbonate and concentrated to precipitate crude crystals of L-malic acid. This was washed with acetone and dried. Prepibacterium
Reaction solution using Flavum MJ-233 bacterial collection 50m/
1.2f of Karake L-malic acid crystals were added, while 2. I got 6f.

発明の効果 フマール酸またはその塩を水溶媒中で酵素反応によりL
 17ンゴ酸を製造する方法において、酵素源としてプ
レピバクテリウム属に桟し α−アミノ酪酸耐性を有す
る微生物、特に積極的にα−アミノ酪酸耐性を付与され
た及び/又けα−アミノ酪酸耐性が高められたプレピバ
クテリウム属に属する微生物を好気的に培養して得られ
る培養物若しくはその処理物を用いるとL  IJンゴ
酸が高い収率で製造することが可能となった。
Effects of the Invention Fumaric acid or its salt is produced by enzymatic reaction in an aqueous solvent.
17 In the method for producing malic acid, microorganisms of the genus Prepibacterium are used as the enzyme source, and microorganisms having α-aminobutyric acid resistance, especially those that have been actively imparted with α-aminobutyric acid resistance and/or α-aminobutyric acid It has become possible to produce LIJ malic acid at a high yield by using a culture obtained by aerobically cultivating a microorganism belonging to the genus Prepibacterium with increased resistance or a processed product thereof.

特許出願人  三菱油化株式会社 代理人 弁理士 古 川 秀 利 代理人 弁理士 長 谷 正 久 −14=Patent applicant: Mitsubishi Yuka Co., Ltd. Agent: Patent Attorney Hidetoshi Furukawa Agent: Patent Attorney Masahisa Nagatani −14=

Claims (1)

【特許請求の範囲】[Claims] (1)プレピバクテリウム属に属し、α−アミノ酪酸耐
性を有する微生物を好気的に培養して得られる培養物若
しくはその処理物の存在下フマール酸またはその塩を水
溶媒中で反応させてL−リンゴ酸を生成させることを特
徴とするL−リンゴ酸の製造法。
(1) Fumaric acid or its salt is reacted in an aqueous solvent in the presence of a culture obtained by aerobically cultivating a microorganism belonging to the genus Prepibacterium and having resistance to α-aminobutyric acid, or a processed product thereof. A method for producing L-malic acid, which comprises producing L-malic acid.
JP10564985A 1985-05-17 1985-05-17 Production of l-malic acid Granted JPS61265096A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP10564985A JPS61265096A (en) 1985-05-17 1985-05-17 Production of l-malic acid
GB08612030A GB2175304B (en) 1985-05-17 1986-05-16 Method of preparing l-malic acid
US06/864,212 US4912043A (en) 1985-05-17 1986-05-19 Method of preparing L-malic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10564985A JPS61265096A (en) 1985-05-17 1985-05-17 Production of l-malic acid

Publications (2)

Publication Number Publication Date
JPS61265096A true JPS61265096A (en) 1986-11-22
JPH0523747B2 JPH0523747B2 (en) 1993-04-05

Family

ID=14413297

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10564985A Granted JPS61265096A (en) 1985-05-17 1985-05-17 Production of l-malic acid

Country Status (1)

Country Link
JP (1) JPS61265096A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5231952A (en) * 1975-09-08 1977-03-10 Nippon Kokan Kk Methoa to control hot extrusion temperature for copper formed products

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5231952A (en) * 1975-09-08 1977-03-10 Nippon Kokan Kk Methoa to control hot extrusion temperature for copper formed products

Also Published As

Publication number Publication date
JPH0523747B2 (en) 1993-04-05

Similar Documents

Publication Publication Date Title
JPS61265096A (en) Production of l-malic acid
US4912043A (en) Method of preparing L-malic acid
JP2721975B2 (en) Method for producing L-lysine
JPH01144989A (en) Production of colominic acid
JPH04349879A (en) Incubation of brevibacterium microorganism
JPS63112992A (en) Production of l-threonine
JPS6251998A (en) Production of l-isoleucine
JPH07102355B2 (en) How to remove dimethylformamide
JPS6342692A (en) Production of l-isoleucine
JPS63160592A (en) Production of l-valine
JPS61177993A (en) Production of l-isoleucine
JPS63192396A (en) Production of l-isoleucine
JPH01120296A (en) Production of l-isoleucine
JPS6291191A (en) Production of l-isoleucine
JPS5928398B2 (en) Method for producing L-isoleucine
JPH02295491A (en) Preparation of l-isoleucine
JPS63267285A (en) Production of l-valine
JPH037590A (en) Production of l-alanine
DE2616673A1 (en) PROCESS FOR THE PRODUCTION OF L (+) - TARTARIC ACID AND ITS SALT
JPS63192395A (en) Production of l-isoleucine
JPH0534955B2 (en)
JPH01120297A (en) Production of l-tyrosine by fermentation process
JPH01101891A (en) Production of l-threonine
JPS63192394A (en) Production of l-isoleucine
JPH01320990A (en) Novel production of l-threonine